Assisting Community-Based Oncologists and Surgeons in Making Neoadjuvant Treatment Decisions for Patients with Early Breast Cancer


Tumor size and the decision to use neoadjuvant treatment in patients with triple-negative disease and a negative axilla clinically
2:46 minutes.

Local disease control and neoadjuvant treatment

Neoadjuvant treatment of HER2-positive tumors

Neoadjuvant treatment of triple-negative tumors

Neoadjuvant treatment of ER-positive, HER2-negative tumors

Other issues in neoadjuvant treatment